Multiple Sclerosis and Fatigue Assessment

Launched by ASLI DEMIRTAŞ · Apr 6, 2023

Keywords

ClinConnect Summary

This clinical trial is focused on understanding fatigue in people with Multiple Sclerosis (MS). Fatigue is a common issue for MS patients, often occurring even without physical activity, and it can significantly impact their daily lives. The researchers aim to compare different ways of measuring fatigue—using patients' own reports, as well as more objective tests—to get a clearer picture of this problem.

To participate in the trial, individuals must be between 18 and 65 years old and have been diagnosed with a specific type of MS called Relapsing Remitting MS. They should be stable in their medical treatment and able to stand independently for at least 60 seconds. Participants will undergo various assessments to evaluate their fatigue levels. It's important to note that individuals with recent MS attacks, who are pregnant, or who have certain other health issues may not be eligible. Overall, this study seeks to improve how fatigue is understood and measured in MS, which could lead to better management strategies in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Being between the ages of 18-65,
• • Having a definite diagnosis of Relapsing Remitting MS by a neurologist,
• • Expanded Disability Status Scale (EDSS) score between 1-5.5,
• • To be stable in medical treatment,
• • Being able to stand independently for at least 60 seconds without any assistive device,
• • It is to be above 24 points according to the Mini-Mental State Examination (MMSE) evaluation.
• Exclusion Criteria:
• • Being diagnosed with MS for less than 1 year,
• • Having had an MS attack in the last 3 months,
• • Being illiterate or unable to communicate in Turkish,
• • Having an active infection,
• • Being pregnant,
• • Having an orthopedic problem or having a surgery that may affect the lower extremity,
• • Having an additional neurological or circulatory disease that may cause balance disorder, a problem affecting the vision or vestibular tract, or a diagnosis of orthopedic surgery, rheumatological disease,
• • To be included in the physiotherapy and rehabilitation program in the last 3 months.